Total Payments
$13,808
2024 Payments
$4,025
Companies
51
Transactions
337
Medicare Patients
12,685
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$10,514 (76.1%)
Consulting$2,500 (18.1%)
Travel$754.72 (5.5%)
Education$39.48 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,514 | 331 | 76.1% |
| Consulting Fee | $2,500 | 1 | 18.1% |
| Travel and Lodging | $754.72 | 4 | 5.5% |
| Education | $39.48 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Peripheral Vascular, Inc. | $3,800 | 17 | $0 (2024) |
| AngioDynamics, Inc. | $1,420 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $1,097 | 58 | $0 (2024) |
| Abbott Laboratories | $971.38 | 17 | $0 (2022) |
| Boston Scientific Corporation | $850.23 | 28 | $0 (2024) |
| Medtronic, Inc. | $606.41 | 10 | $0 (2024) |
| Merck Sharp & Dohme LLC | $390.98 | 22 | $0 (2024) |
| Avinger Inc. | $388.53 | 8 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $328.08 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $315.78 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,025 | 39 | Bard Peripheral Vascular, Inc. ($2,954) |
| 2023 | $949.46 | 29 | Bard Peripheral Vascular, Inc. ($233.81) |
| 2022 | $1,913 | 56 | Bard Peripheral Vascular, Inc. ($456.06) |
| 2021 | $1,231 | 36 | Abbott Laboratories ($380.08) |
| 2020 | $1,202 | 50 | Janssen Pharmaceuticals, Inc ($355.80) |
| 2019 | $1,790 | 67 | Abbott Laboratories ($355.81) |
| 2018 | $1,026 | 40 | Boston Scientific Corporation ($221.92) |
| 2017 | $1,672 | 20 | AngioDynamics, Inc. ($1,218) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Philips North America LLC | (BR5) Peripheral IVUS (Device) | Food and Beverage | Cash or cash equivalent | $70.27 | General |
| Category: Medical Device | ||||||
| 12/18/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Genetic Disease | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: DIABETES | ||||||
| 10/14/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Heart Failure and Hypertension | ||||||
| 09/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Obesity | ||||||
| 08/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: General - Vascular Intervention_PI | ||||||
| 08/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $22.27 | General |
| 08/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/12/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/07/2024 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $166.93 | General |
| Category: Vascular/Oncology | ||||||
| 08/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/16/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $27.54 | General |
| Category: Heart Failure and Hypertension | ||||||
| 07/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/01/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $31.27 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/06/2024 | Bard Peripheral Vascular, Inc. | Venclose Maven Catheter (Device) | Food and Beverage | In-kind items and services | $45.48 | General |
| Category: Vascular/Oncology | ||||||
| 05/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/07/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/29/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/17/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $33.61 | General |
| Category: Medical Device | ||||||
| 04/15/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,769 | 3,947 | $1.6M | $451,927 |
| 2022 | 32 | 3,360 | 4,875 | $1.6M | $517,022 |
| 2021 | 34 | 3,308 | 4,678 | $1.7M | $537,682 |
| 2020 | 32 | 3,248 | 4,932 | $1.8M | $564,710 |
Total Patients
12,685
Total Services
18,432
Medicare Billing
$2.1M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 505 | 804 | $261,300 | $74,263 | 28.4% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 50 | 83 | $303,614 | $69,164 | 22.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 194 | 196 | $230,888 | $61,211 | 26.5% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 31 | 37 | $123,284 | $38,364 | 31.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 192 | 384 | $45,254 | $34,368 | 75.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 189 | 189 | $93,744 | $23,315 | 24.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 128 | 516 | $55,728 | $22,134 | 39.7% |
| 36466 | Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance | Office | 2023 | 14 | 16 | $59,116 | $17,940 | 30.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $43,992 | $11,573 | 26.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 65 | 65 | $40,885 | $10,744 | 26.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 213 | 216 | $38,232 | $10,233 | 26.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 75 | 76 | $36,404 | $9,280 | 25.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 54 | 54 | $27,540 | $7,123 | 25.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 75 | $19,875 | $7,036 | 35.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 56 | 57 | $26,562 | $6,935 | 26.1% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 63 | 76 | $22,572 | $6,596 | 29.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 47 | 49 | $22,295 | $6,354 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 89 | $20,319 | $5,802 | 28.6% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 20 | 20 | $13,700 | $4,116 | 30.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $14,674 | $4,034 | 27.5% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 44 | 44 | $10,689 | $3,149 | 29.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 25 | 29 | $5,394 | $1,840 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 171 | 177 | $7,611 | $1,801 | 23.7% |
| 78472 | Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | Office | 2023 | 12 | 12 | $6,864 | $1,784 | 26.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $5,950 | $1,780 | 29.9% |
About Dr. Christopher Edwards, DO
Dr. Christopher Edwards, DO is a Internal Medicine healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2010. The National Provider Identifier (NPI) number assigned to this provider is 1821307877.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Edwards, DO has received a total of $13,808 in payments from pharmaceutical and medical device companies, with $4,025 received in 2024. These payments were reported across 337 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($10,514).
As a Medicare-enrolled provider, Edwards has provided services to 12,685 Medicare beneficiaries, totaling 18,432 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Jacksonville, FL
- Active Since 09/24/2010
- Last Updated 04/04/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1821307877
Products in Payments
- XARELTO (Drug) $1,097
- Venclose Maven Catheter (Device) $454.38
- ELIQUIS (Drug) $443.69
- PANTHERIS (Device) $388.53
- VERQUVO (Drug) $371.35
- Omnilink Elite vascular stent system (Device) $278.05
- INTERVENTIONAL ANGIOGRAPHY SYSTEM (Device) $273.22
- ENTRESTO (Drug) $266.92
- LINQ II (Device) $251.21
- EVRSF (Device) $231.79
- OptoWire (Device) $227.54
- Supera peripheral stent system (Device) $202.22
- Barostim Neo System (Device) $190.55
- GENERAL VASCULAR INTERVENTION (Device) $178.27
- HawkOne (Device) $163.95
- ABRE (Device) $159.04
- General - Vascular Intervention (Device) $146.01
- NEXLETOL (Drug) $143.34
- Xact carotid stent system (Device) $125.06
- Repatha (Biological) $119.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jacksonville
Siddharth Wayangankar, Md, MD
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Alan Miller, M.d, M.D
Internal Medicine — Payments: $770,575
Internal Medicine $770,575
Kalina Sanders, M.d, M.D
Internal Medicine — Payments: $626,907
Internal Medicine $626,907
Jose Soto Soto, Md, MD
Internal Medicine — Payments: $576,809
Internal Medicine $576,809
Dr. Jennifer Fulton, Md, MD
Internal Medicine — Payments: $556,016
Internal Medicine $556,016
Dr. Francis Farraye, M.d, M.D
Internal Medicine — Payments: $504,399
Internal Medicine $504,399